Psychedelic Drugs to Treat Mental and Behavioral Health Conditions

February 1, 2022 | Technology Forecasts

Preview

Psychedelic drugs (eg, psilocybin, lysergic acid diethylamide LSD, N,N-dimethyltryptamine DMT, 3,4-methylenedioxymethamphetamine MDMA, ketamine) alter one's state of consciousness, purportedly by altering certain neurotransmitters in the brain. Their use might provide the user with altered perception, increased introspection, feelings of closeness with others, and positive mood states. These experiences are often reported as deeply profound and life-altering.

Although most psychedelics are designated as Schedule I drugs in the United States, researchers are investigating their...

Access Full Content

Contact us today at 610.825.6000.